Fluotracen

Fluotracen (SKF-28,175) is a tricyclic drug which has both antidepressant and antipsychotic activity.^[1][2][3] This profile of effects is similar to that of related agents like amoxapine, loxapine, and trimipramine which may also be used in the treatment of both depression and psychosis.^[1] It was believed that such duality would be advantageous in the treatment of schizophrenia, as depression is often comorbid with the disorder and usual antipsychotics often worsen such symptoms.^[1] In any case, however, fluotracen was never marketed.^[3]

Fluotracen

Clinical data
Routes of administration	Oral
ATC code	none
Legal status
Legal status	In general: uncontrolled
Identifiers
IUPAC name N,N-dimethyl-3-[10-methyl-2-(trifluoromethyl)-9,10-dihydroanthracen-9-yl]propan-1-amine
CAS Number	35764-73-9 57363-14-1 (HCl)
PubChem CID	42291
ChemSpider	38565
UNII	3026WKR55S
CompTox Dashboard (EPA)	DTXSID10865788
Chemical and physical data
Formula	C21H24F3N
Molar mass	347.425 g·mol−1
3D model (JSmol)	Interactive image
SMILES FC(F)(F)c1ccc3c(c1)C(c2ccccc2C3C)CCCN(C)C

See also

• Litracen
• Melitracen